The availability of suitable drug delivery systems to direct drugs to their specific site of action, with reduced side effects, whilst protecting cytotoxic and unstable drugs, remains an important need for the pharmaceutical and biotech industry. Researchers at The University of Queensland’s Institute for Molecular Bioscience have developed the ‘Caveosphere™’, a novel drug delivery vehicle.

UniQuest Contact: 

Stephen Earl

Position: 
Director, Commercial Engagement - Therapeutics (Health)
Mobile phone: 
+61 421 780 689
Work phone: 
+61 (7) 3365 4037